Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 162.25
+1.35 (0.84%)
Sep 24, 2026, 5:30 PM CET
Galderma Group AG Market Cap
Galderma Group AG has a market cap or net worth of 37.83 billion as of September 24, 2026. Its market cap has increased by 14.08% in one year.
Market Cap
37.83B
Enterprise Value
39.35B
Revenue
4.79B
Ranking
n/a
PE Ratio
54.98
Stock Price
162.25
ChartMarket Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 15.20B to 37.83B, an increase of 148.84%. That is a compound annual growth rate of 43.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 37.83B | -1.69% |
| Dec 30, 2025 | 38.48B | 60.96% |
| Dec 30, 2024 | 23.91B | 57.25% |
| Mar 22, 2024 | 15.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 291.29B |
| Novartis AG | 221.36B |
| Lonza Group AG | 39.31B |
| Sandoz Group AG | 30.62B |
| Alcon | 25.99B |
| Straumann Holding AG | 15.60B |
| Sonova Holding AG | 14.23B |
| Bachem Holding AG | 6.26B |